| 000 | 01507 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250512130929.0 | ||
| 264 | 0 | _c19741009 | |
| 008 | 197410s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1002/cpt1974161part2183 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzarnoff, D L | |
| 245 | 0 | 0 |
_aApplication of blood level data to clinical trials. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cJul 1974 |
||
| 300 |
_a183-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAlkylating Agents _xpharmacology |
| 650 | 0 | 4 | _aBiopharmaceutics |
| 650 | 0 | 4 |
_aDisease _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Therapy |
| 650 | 0 | 4 | _aEnvironment |
| 650 | 0 | 4 | _aGenetics |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
| 650 | 0 | 4 | _aPatients |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xblood |
| 650 | 0 | 4 |
_aPractolol _xpharmacology |
| 650 | 0 | 4 |
_aPropranolol _xpharmacology |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aReceptors, Drug |
| 650 | 0 | 4 |
_aWarfarin _xblood |
| 650 | 0 | 4 | _aWater-Electrolyte Balance |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 16 _gno. 1 _gp. 183-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpt1974161part2183 _zAvailable from publisher's website |
| 999 |
_c4846414 _d4846414 |
||